DPAM
CRL icon

Degroof Petercam Asset Management’s Charles River Laboratories CRL Stock Holding History

Degroof Petercam Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$325K Hold
1,200
– – ﹤0.01% 549
2023
Q4 		$284K Buy
+1,200
New +$236K ﹤0.01% 566

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Degroof Petercam Asset Management's CRL Position: Q1 2024 in Review

Degroof Petercam Asset Management held its Charles River Laboratories (CRL) position steady in Q1 2024 at 1,200 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Degroof Petercam Asset Management first reported a position in CRL in Q4 2023 and has held it in 2 quarters since. 677 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

  • Degroof Petercam Asset Management held 1,200 shares of Charles River Laboratories worth $325K as of Q1 2024.
  • Degroof Petercam Asset Management left its Charles River Laboratories share count unchanged in Q1 2024.
  • Charles River Laboratories made up ﹤0.01% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #549 holding.
  • Degroof Petercam Asset Management first reported a position in Charles River Laboratories in Q4 2023 and has held it in 2 quarters since.
  • 677 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.